It is estimated that approximately 340,000 Americans and 100,000 Canadians are injection drug users (IDUs). Injection drug use can lead to overdose death, infectious disease spread, loss of social and economic functioning, and extensive engagement in criminal activity. For these reasons, interventions that may affect the natural history of injecton drug use, and in turn reduce these consequences, are of international interest. This study proposes to: determine the incidence of initiation into injection drug use among high-risk non-injection drug using youth and to elucidate individual, cultural, and environmental risk factors for initiation of injection; to evaluate the natural history of injection drug use from initiation to cessation or death, and to examine how specific environmental factors and interventions, such as prevention programs or addiction treatment interventions, can influence this natural history; to determine individual, cultural, and environmental barriers to the use of secondary prevention services, addiction treatment, and medical care; and to evaluate how trends in service use affect the incidence of HIV and associated risk behaviors as well as rates of mortality among a cohort of active IDUs. Vancouver is ideally suited to the proposed research questions for several reasons. First, the incidence of initiation into injection drug use among high-risk youth in our setting remains high. Second, the city is home to ongoing high rates of overdose mortality and HIV incidence among active IDUs. Second, British Columbia has a province-wide, centralized program of free access to highly active antiretroviral therapy (HAART), and a universal healthcare system that provides all medical care, including addiction treatment, free of charge. Understanding the mechanisms and interventions that affect the natural history of injection drug use, and the incidence of the consequences of injection drug use, are critical questions in North America. As such, this project will help inform prevention strategies and interventions throughout North America and elsewhere.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA011591-07
Application #
7263169
Study Section
AIDS Clinical Studies and Epidemiology Study Section (ACE)
Program Officer
Lambert, Elizabeth
Project Start
1998-06-05
Project End
2009-07-31
Budget Start
2007-08-01
Budget End
2008-07-31
Support Year
7
Fiscal Year
2007
Total Cost
$472,922
Indirect Cost
Name
University of British Columbia
Department
Type
DUNS #
251949962
City
Vancouver
State
BC
Country
Canada
Zip Code
V6 1-Z3
Damon, Will; Small, Will; Anderson, Solanna et al. (2017) 'Crisis' and 'everyday' initiators: A qualitative study of coercion and agency in the context of methadone maintenance treatment initiation. Drug Alcohol Rev 36:253-260
Luongo, Nicole M; Dong, Huiru; Kerr, Thomas H et al. (2017) Income generation and attitudes towards addiction treatment among people who use illicit drugs in a Canadian setting. Addict Behav 64:159-164
Krüsi, Andrea; McNeil, Ryan; Moore, David et al. (2017) 'Because I've been extremely careful': HIV seroconversion, responsibility, citizenship and the neo-liberal drug-using subject. Health Risk Soc 19:58-73
Kerr, Thomas; Shannon, Kate; Ti, Lianping et al. (2016) Sex work and HIV incidence among people who inject drugs. AIDS 30:627-34
Werb, Daniel; Garfein, Richard; Kerr, Thomas et al. (2016) A socio-structural approach to preventing injection drug use initiation: rationale for the PRIMER study. Harm Reduct J 13:25
Bach, Paxton; Walton, Geoffrey; Hayashi, Kanna et al. (2016) Benzodiazepine Use and Hepatitis C Seroconversion in a Cohort of Persons Who Inject Drugs. Am J Public Health 106:1067-72
Escudero, Daniel J; Marshall, Brandon D L; Kerr, Thomas et al. (2016) No association between HIV status and risk of non-fatal overdose among people who inject drugs in Vancouver, Canada. Addict Behav 60:8-12
Caudarella, Alexander; Dong, Huiru; Milloy, M J et al. (2016) Non-fatal overdose as a risk factor for subsequent fatal overdose among people who inject drugs. Drug Alcohol Depend 162:51-5
Montain, Jacqueline; Ti, Lianping; Hayashi, Kanna et al. (2016) Impact of length of injecting career on HIV incidence among people who inject drugs. Addict Behav 58:90-4
Poon, Art F Y; Gustafson, Réka; Daly, Patricia et al. (2016) Near real-time monitoring of HIV transmission hotspots from routine HIV genotyping: an implementation case study. Lancet HIV 3:e231-8

Showing the most recent 10 out of 185 publications